Top

Published in:

01-02-2019 | Original Article

IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist

Authors: S. Manfrida, V. Masiello, F. Cellini, E. Adducci, L. Polidori, S. Longo, G. Cannelli, M. Balducci, M. Rossi, V. Valentini

Published in: Supportive Care in Cancer | Issue 2/2019

Abstract

Purpose

Purpose of this study was to retrospectively review our experience of multidisciplinary clinic providing a joint approach by radiation oncologist and anesthetist for patients with cancer pain to evaluate the adequacy and the IMprovement in MAnagement (IM-MA study) of this symptom.

Methods

A Team for Pain Management (TPM) represented by radiation oncologist and anesthetist weekly provided consultations to patient presenting cancer pain. TPM prospectively reported epidemiologic, symptomatic, and pharmacological data. TPM modified pain therapy and indicated antalgic radiotherapy. Patients were evaluated at baseline and after 4 weeks after intervention.

Results

From November 2015 to April 2016, 65 patients were evaluated by TPM. At the baseline, 18 patients (27.7%) were undertreated (i.e., receiving inadequate pain management); furthermore, 27 patients (41.5%) despite receiving strong opioids had uncontrolled pain. After 4 weeks from intervention, undertreated patients were reduced to 1.53%. For those patients undergone to radiotherapy, response at 34 weeks was scored as follows: complete response 28.8%, partial response 46.7%, pain progression 0.95%, indeterminate response 23.8%.

Conclusions

A multidisciplinary Team for Pain Management improved the clinical management, optimizing pain control and increasing adequacy of pharmacological management. The TPM intervention seems particularly worth for patients presenting specific features including BTcP, neuropathic pain, severe pain due to bone metastases, and any potential candidate to radiotherapy. Larger series and QoL questionnaires are required to confirm these results.

Mitera G, Fairchild A, DeAngelis C, Emmenegger U, Zurawel-Balaura L, Zhang L, Bezjak A, Levin W, Mclean M, Zeiadin N, Pang J, Nguyen J, Sinclair E, Chow E, Wong R (2010) A multicenter assessment of the adequacy of cancer pain treatment using the pain management index. J Palliat Med 13(5):589–593. https://doi.org/10.1089/jpm.2009.0342 CrossRefPubMed

Van den Beuken-van Everdingen MH, De Rijke JM, Kessels AG, Schouten HC, Van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437–1449CrossRef

World Health Organization, Cancer pain relief (1996) with a guide to opioid availability, 2nd edn. Geneva, Switzerland

Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G, European Palliative Care Research Collaborative (EPCRC) (2012) Use of opioids in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58–e68. https://doi.org/10.1016/S1470-2045(12)70040-2 CrossRef

Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F, ESMO Guidelines Working Group (2012) Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 23(Suppl 7):vii139–vii154CrossRef

Ripamonti CI (2012) Pain management. Ann Oncol 23(Suppl 10):294–301CrossRef

Foley KM (2011) How well is cancer pain treated? Palliat Med 25(5):398–401. https://doi.org/10.1177/0269216311400480 CrossRefPubMed

Janjan NA, Payne R, Gillis T, Podoloff D, Libshitz HI, Lenzi R, Theriault R, Martin C, Yasko A (1998) Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manag 16(3):171–178CrossRef

Vuong S, Pulenzas N, DeAngelis C, Torabi S, Ahrari S, Tsao M, Danjoux C, Barnes T, Chow E (2016) Inadequate pain management in cancer patients attending an outpatient palliative radiotherapy clinic. Support Care Cancer 24(2):887–892. https://doi.org/10.1007/s00520-015-2858-7 CrossRefPubMed

10.

Massaccesi M, Deodato F, Caravatta L, Macchia G, Padula GD, Di Rito S, Woldemariam AA, Rossi M, Di Falco C, Tambaro R, Mignogna S, Flocco M, Pacelli F, Valentini V, Cellini N, Morganti AG (2013) Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center. Clin J Pain 29(11):944–947CrossRef

11.

Yau V, Chow E, Davis L, Holden L, Schueller T, Danjoux C (2004) Pain management in cancer patients with bone metastases remains a challenge. J Pain Symptom Manag 27(1):1–3CrossRef

12.

Pituskin E, Fairchild A, Dutka J, Gagnon L, Driga A, Tachynski P, Borschneck JA, Ghosh S (2010) Multidisciplinary team contributions within a dedicated outpatient palliative radiotherapy clinic: a prospective descriptive study. Int J Radiat Oncol Biol Phys 78(2):527–532. https://doi.org/10.1016/j.ijrobp.2009.07.1698 CrossRefPubMed

13.

Gagnon L, Fairchild A, Pituskin E, Dutka J, Chambers C (2012) Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: contributions of a clinical pharmacist. J Oncol Pharm Pract 18(1):76–83. https://doi.org/10.1177/1078155211402104 CrossRefPubMed

14.

Bandieri E, Sichetti D, Romero M, Fanizza C, Belfiglio M, Buonaccorso L, Artioli F, Campione F, Tognoni G, Luppi M (2012) Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer. Ann Oncol 23(8):2016–2020. https://doi.org/10.1093/annonc/mds103 CrossRefPubMed

15.

Nieder C, Dalhaug A, Pawinski A, Haukland E, Mannsåker B, Engljähringer K (2015) Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team: a retrospective comparison. Radiat Oncol 10(61). https://doi.org/10.1186/s13014-015-0365-0

16.

Cheon PM, Wong E, Thavarajah N, Dennis K, Lutz S, Zeng L, Chow E (2015) A definition of “uncomplicated bone metastases” based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapy. J Bone Oncol 4(1):13–17. https://doi.org/10.1016/j.jbo.2014.12.001 CrossRefPubMedPubMedCentral

17.

Hawker GA, Mian S, Kendzerska T, French M (2011) Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 63(Suppl 11):S240–S252. https://doi.org/10.1002/acr.20543 CrossRef

18.

Li KK, Harris K, Hadi S, Chow E (2007) What should be the optimal cutpoints for mild, moderate and severe pain? J Palliat Med 10(6):1338–1346CrossRef

19.

Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61(2):277–284CrossRef

20.

Kirou-Mauro AM, Hird A, Wong J, Sinclair E, Barnes EA, Tsao M, Danjoux C, Chow E (2009) Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. J Pain Symptom Manag 37(1):77–84. https://doi.org/10.1016/j.jpainsymman.2007.12.014 CrossRef

21.

Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64(3):275–280CrossRef

22.

Chow E, Hoskin P, Mitera G, Zeng L, Lutz S, Roos D, Hahn C, van der Linden Y, Hartsell W, Kumar E (2012) International Bone Metastases Consensus Working Party. Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82(5):1730–1737. https://doi.org/10.1016/j.ijrobp.2011.02.008 CrossRefPubMed

23.

Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19(12):1985–1991. https://doi.org/10.1093/annonc/mdn419 CrossRefPubMedPubMedCentral

24.

Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330(9):592–596CrossRef

25.

Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, Apolone G (2014) Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 32:4149–4154. https://doi.org/10.1200/JCO.2014.56.0383 CrossRefPubMed

26.

Maltoni M (2008) Opioids, pain, and fear. Ann Oncol 19(1):5–7CrossRef

27.

Apolone G, Corli O, Caraceni A, Negri E, Deandrea S, Montanari M, Greco MT, Cancer Pain Outcome Research Study Group (CPOR SG) Investigators (2009) Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 100:1566–1574CrossRef

28.

Mercadante S, Roila F, Berretto O, Labianca R, Casilini S, DOMAIN-AIOM study group (2008) Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey. Support Care Cancer 16(11):1203–1211. https://doi.org/10.1007/s00520-008-0456-7 CrossRefPubMed

Title: IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist
Authors: S. Manfrida
V. Masiello
F. Cellini
E. Adducci
L. Polidori
S. Longo
G. Cannelli
M. Balducci
M. Rossi
V. Valentini
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 2/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4335-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Clinical and epidemiological factors associated with suicide in colorectal cancer

Reply to: Letter on “Objective and subjective financial burden and health-related quality of life among lung cancer patients” by Joohyun Park

A prospective and population-based inquiry on the use and acceptability of peer support for women newly diagnosed with breast cancer

Hispanic breast cancer patients’ symptom experience and patient-physician communication during chemotherapy

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants

Keynote webinar | Spotlight on antibody–drug conjugates in cancer